Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1993 1
1994 2
1996 1
1997 4
1998 3
1999 3
2000 1
2001 1
2002 5
2003 2
2004 3
2005 1
2009 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Verrucous Haemangioma.
Mani MZ, Feierabend CT. Mani MZ, et al. Among authors: feierabend ct. Indian J Dermatol Venereol Leprol. 1982 Mar-Apr;48(2):116-117. Indian J Dermatol Venereol Leprol. 1982. PMID: 28193978
A phase I study of 5-fluorouracil, leucovorin and levamisole.
Cleary JF, Arzoomanian R, Alberti D, Feierabend C, Storer B, Witt P, Carbone P, Wilding G. Cleary JF, et al. Among authors: feierabend c. Cancer Chemother Pharmacol. 1997;39(4):300-6. doi: 10.1007/s002800050576. Cancer Chemother Pharmacol. 1997. PMID: 9025770 Clinical Trial.
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
Mulkerin D, LoConte NK, Holen KD, Thomas JP, Alberti D, Marnocha R, Kolesar J, Eickhoff J, Oliver K, Feierabend C, Wilding G. Mulkerin D, et al. Among authors: feierabend c. Invest New Drugs. 2009 Oct;27(5):461-8. doi: 10.1007/s10637-008-9210-8. Epub 2009 Jan 8. Invest New Drugs. 2009. PMID: 19129971 Free PMC article. Clinical Trial.
Phase I clinical and pharmacokinetic trial of irofulven.
Thomas JP, Arzoomanian R, Alberti D, Feierabend C, Binger K, Tutsch KD, Steele T, Marnocha R, Smith C, Smith S, MacDonald J, Wilding G, Bailey H. Thomas JP, et al. Among authors: feierabend c. Cancer Chemother Pharmacol. 2001 Dec;48(6):467-72. doi: 10.1007/s002800100365. Cancer Chemother Pharmacol. 2001. PMID: 11800027 Clinical Trial.
Phase I trial of perillyl alcohol administered four times daily continuously.
Morgan-Meadows S, Dubey S, Gould M, Tutsch K, Marnocha R, Arzoomanin R, Alberti D, Binger K, Feierabend C, Volkman J, Ellingen S, Black S, Pomplun M, Wilding G, Bailey H. Morgan-Meadows S, et al. Among authors: feierabend c. Cancer Chemother Pharmacol. 2003 Nov;52(5):361-6. doi: 10.1007/s00280-003-0684-y. Epub 2003 Aug 2. Cancer Chemother Pharmacol. 2003. PMID: 12904896 Clinical Trial.
A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Robins HI, Katschinski DM, Longo W, Grosen E, Wilding G, Gillis W, Kraemer C, Tiggelaar CL, Rushing D, Stewart JA, Spriggs D, Love R, Arzoomanian RZ, Feierabend C, Alberti D, Morgan K, Simon K, d'Oleire F. Robins HI, et al. Among authors: feierabend c. Cancer Chemother Pharmacol. 1999;43(5):409-14. doi: 10.1007/s002800050915. Cancer Chemother Pharmacol. 1999. PMID: 10100597
30 results